Q1. Could you please provide the numbers of patients treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Apremilast
d. Brodalumab
e. Certolizumab
f. Dimethyl fumarate
g. Etanercept – Enbrel
h. Etanercept Biosimilar
i. Guselkumab
j. Infliximab – Remicade
k. Infliximab Biosimilar
l. Ixekizumab
m. Risankizumab
n. Secukinumab
o. Tildrakizumab
p. Ustekinumab
Q2. Could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab
Q3. If possible, could you please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for Ulcerative Colitis ONLY with the following biologic drugs:
a. Adalimumab – Humira
b. Adalimumab Biosimilar
c. Golimumab
d. Infliximab – Remicade
e. Infliximab Biosimilar
f. Tofacitinib
g. Ustekinumab
h. Vedolizumab
